Q4 2023 Vistagen Therapeutics Inc Earnings Call Transcript
Greetings, and welcome to Vistagen Therapeutic's Fiscal Year End 2023 Corporate Update Conference Call. (Operator Instructions). As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mark McPartland Senior Vice President of Investor Relations. Thank you. You may begin.
Thank you, Doug. Good afternoon, everyone, and welcome to Vistagen's fiscal year-end 2023 corporate update conference call and webcast. This afternoon, we issued a press release providing an overview of our progress last year and future milestones, and we expect to file our fiscal year-end 10-K later this afternoon. We would encourage you to review both, which can be found under the Investors section of our website.
Now before we start today's call, I want to remind you that we may make forward-looking statements regarding our business based on our current expectations and information. The forward-looking statements speak only as of today, and except as required by law, we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |


